Newsroom

Person wehrt Viren ab
News
For a long time, itaconic acid was only known as a metabolic product of fungi. Its function was unknown, but for decades it has been used industrially for polymer production. In 2013, it was surprisingly discovered as an important metabolic product in the immune system. This newly described role has sparked a search for potential clinical applications. Researchers at the Helmholtz Centre for Infection Research (HZI) and TWINCORE-Centre for Experimental and Clinical Infection Research, jointly founded by the HZI and the Hanover Medical School, have now solved the crystal structure of the itaconic acid-synthesizing enzyme cis-aconitate decarboxylase (CAD). Their findings provide the basis for an improved understanding of itaconic acid synthesis, the evolutionary origin of this important metabolic step, and the role of itaconic acid in the immune system. In particular, the researchers identified naturally occurring and possibly clinically important variations in the human CAD enzyme.
26.09.2019
Nasenspray
News
Ascenion GmbH, technology transfer partner of the Helmholtz Centre for Infection Research (HZI), announces the take-over of its portfolio company WBC Drug Delivery Technologies (WBC) by Klaria Pharma Holding AB in an all-stock deal. WBC was founded earlier this year to further advance a new drug delivery technology that was co-developed by scientists at the HZI and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a HZI branch. The researchers coated liposomes with invasins, proteins that enable bacteria to penetrate eukaryotic cell membranes. The resulting carrier system combines the safety and versatility of liposomes with the unique capacity of bacteria to invade human cells. It holds strong potential to improve the treatment of many diseases, also intracellular infections caused by pathogens "hiding" in membrane-bound vacuoles.
19.09.2019
Impfung
News
If you want to protect yourself from the flu, you have to be vaccinated anew every year because the viruses are constantly changing the components to which our immune system responds. Our immune system primarily reacts to the two viral proteins haemagglutinin (HA) and neuraminidase (NA), although it has been shown that today’s vaccines only trigger a weak immune response against neuraminidase in the vaccinated individuals. This is unfortunate, as evidence suggests that sufficient antibodies against NA can be at least as effective against influenza infections as those against haemagglutinin. The researchers now want to make better use of this effect.
05.09.2019
Parasit Trypanosoma cruzi
News
With their project Vaccine for Prevention and Treatment of Trypanosoma cruzi Infection (CRUZIVAX), a consortium of eleven partners coordinated by the Helmholtz Centre for Infection Research has been awarded funding through the European Commission’s Horizon 2020 work programme. The aim of this project is to develop a highly effective, low-cost and easy to administer prophylactic vaccine candidate for Chagas disease, which is caused by the parasite Trypanosoma cruzi (T. cruzi). The vaccine is to be applied as a nasal spray. The project is coordinated by the Vaccinology department of the Helmholtz Centre for Infection Research (HZI) in Braunschweig under the direction of Prof Carlos A. Guzmán. The total funding amounts to more than eight million euros over a period of five years, about two million euros being provided to the HZI.
25.07.2019
grafische Darstellung des Enzyms PurAH
News
In the 1950s, researchers discovered bottromycins – natural substances produced by bacteria with antibiotic activity. Since these substances even kill human pathogens such as the hospital germ MRSA (methicillin-resistant Staphylococcus areus), they are of interest for drug development. After the discovery of bottromycins, it took until 2012 before researchers from the Helmholtz Centre for Infection Research (HZI) and its Saarbrücken location, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), were able to identify the genes that bacteria need to form bottromycins. Now they were able to further unravel the underlying reactions in the bacterial cells.
20.06.2019
DNA
News
As part of the “Big Data in den Lebenswissenschaften der Zukunft” (“Big data in the life sciences of the future”) call, the Lower Saxony Ministry of Science and Culture and the Volkswagen Foundation are supporting 16 innovative projects that are focused on the opportunities offered by data-intensive research and personalised medicine. The life sciences are currently among the most dynamic research fields in science – as shown by the fact that 54 applications were submitted. Funding will be provided for research projects that make particular use of the opportunities and possibilities resulting from the ongoing digitalisation of life sciences for the advancement of knowledge. These projects develop milestones for the transfer of newly acquired knowledge and implement its initial steps. A total of five projects involving the Helmholtz Centre for Infection Research (HZI) have received funding.
18.06.2019

HZI in the media

Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig erwartet insgesamt einen typischen

12.11.2026
|
Wiesbadener Kurier

... Technischen Universität Braunschweig, Forschungsgruppenleiter am Helmholtz Zentrum für Infektionsforschung.

 

Nach seiner Promotion über ...

09.11.2026
|
Radio38

WDR am 05.11.2026: Vitamine sind lebenswichtig. Viele greifen deshalb zu Kapseln, Pulvern und Brausetabletten, um mit einer Extraportion nachzuhelfen.

 

Das Geschäft boomt: Hersteller versprechen mehr Energie, ein stärkeres Immunsystem, gesünderes Altern und Schutz vor Krankheiten

06.11.2026
|
ARD Mediathek

Jörg Vogel, Direktor des Helmholtz-Instituts für RNA-basierte Infektionsforschung und Sprecher der Leopoldina-Arbeitsgruppe RNA-basierte ...

04.11.2026
|
Tagesschau

... Team der MHH beteiligen sich das Helmholtz-Zentrum für Infektionsforschung, das Fraunhofer-Institut für Toxikologie und ...

04.11.2026
|
Deutsches Ärzteblatt

... leitete er eine Forschungsgruppe am Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI) in Würzburg.

 

Vorbeugen - ...

02.11.2026
|
Management & Krankenhaus

"Trump ist eine Bedrohung für die Demokratie und Freiheit. Eine Rückkehr in die USA ist beruflich keine Option mehr", so Biologin Dr. Elsa Anderson. Forschenden droht in den USA in der zweiten Amtszeit von Donald Trump der Verlust ihrer wissenschaftlichen Freiheit, sie suchen des

02.11.2026
|
arte

... nach dem Saarland benannt.

 

Seit gut drei Jahren läuft das vom Helmholtz-Institut für Pharmazeutische Forschung ...

02.11.2026
|
Tagesschau

... ist Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung (HZI) und Mitglied der Ständigen Impfkommission ...

30.10.2026
|
Focus Online

von Mikroorganismen und Zellkulturen und des Helmholtz-Zentrums für Infektionsforschung zwei bislang unbekannte Naturstoffe entdeckt. Die

30.10.2026
|
Bionity.COM

Researchers at the Helmholtz Centre for Infection Research (HZI) and its Saarland University partner site, the Helmholtz Institute for

27.10.2026
|
Scienmag Science Magazine

experimental and modeling study led by scientists at the Helmholtz Centre for Infection Research in Braunschweig. The researchers found that

26.10.2026
|
Bioengineer.org

Register now for the HZI newsletter